PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Ocugen, Inc. (OCGN)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US67577C1053

CUSIP

67577C105

Sector

Healthcare

IPO Date

Dec 3, 2014

Highlights

Market Cap

$302.25M

EPS (TTM)

-$0.17

Total Revenue (TTM)

$8.19M

Gross Profit (TTM)

$7.26M

EBITDA (TTM)

-$35.35M

Year Range

$0.36 - $2.11

Target Price

$6.25

Short %

18.35%

Short Ratio

14.10

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
OCGN vs. NVAX OCGN vs. VTSAX OCGN vs. NNN OCGN vs. SPY OCGN vs. SCHD OCGN vs. VOO OCGN vs. NVDA
Popular comparisons:
OCGN vs. NVAX OCGN vs. VTSAX OCGN vs. NNN OCGN vs. SPY OCGN vs. SCHD OCGN vs. VOO OCGN vs. NVDA

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Ocugen, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%10.00%JuneJulyAugustSeptemberOctoberNovember
-51.85%
11.08%
OCGN (Ocugen, Inc.)
Benchmark (^GSPC)

Returns By Period

Ocugen, Inc. had a return of 64.56% year-to-date (YTD) and 143.24% in the last 12 months.


OCGN

YTD

64.56%

1M

0.66%

6M

-50.72%

1Y

143.24%

5Y (annualized)

26.78%

10Y (annualized)

N/A

^GSPC (Benchmark)

YTD

23.62%

1M

0.54%

6M

11.19%

1Y

30.63%

5Y (annualized)

13.61%

10Y (annualized)

11.16%

Monthly Returns

The table below presents the monthly returns of OCGN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-6.80%74.66%75.21%-19.51%31.06%-10.40%-9.35%-7.47%-23.68%-8.18%64.56%
2023-2.31%-21.57%-14.36%-16.30%-35.57%18.04%13.26%-29.92%-7.19%-8.00%5.16%48.58%-55.77%
2022-21.98%-0.85%-6.25%-33.64%8.22%-4.22%13.66%0.00%-31.01%-3.37%-9.30%-16.67%-71.43%
2021-3.28%518.64%-37.99%86.60%-31.10%-8.02%-16.44%13.11%-5.40%64.90%-46.45%-28.23%148.63%
20201.92%-15.09%-37.56%11.39%-0.96%-29.03%134.09%-32.43%-10.92%-9.35%13.52%473.67%251.92%
2019136.36%-40.38%-6.45%62.93%1.59%-0.52%-5.76%33.33%-80.21%-43.16%-76.60%37.20%-90.15%
201835.12%-6.86%6.59%-3.64%-12.83%8.23%-11.60%32.13%-81.34%25.69%-37.52%-79.44%-95.71%
2017-4.79%5.03%3.59%0.58%-7.47%11.18%3.35%-0.54%7.61%7.58%-6.57%3.02%22.75%
2016-14.00%-13.62%-11.92%-0.87%-18.06%-8.06%12.16%62.15%3.22%-16.20%-28.25%-13.47%-52.29%
2015-23.15%26.21%-6.37%-18.32%2.33%-22.63%-1.32%-2.90%-35.64%3.16%-19.95%6.38%-68.18%
2014-6.38%-6.38%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current risk-adjusted rank of OCGN is 82, placing it in the top 18% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of OCGN is 8282
Combined Rank
The Sharpe Ratio Rank of OCGN is 8585
Sharpe Ratio Rank
The Sortino Ratio Rank of OCGN is 8585
Sortino Ratio Rank
The Omega Ratio Rank of OCGN is 7878
Omega Ratio Rank
The Calmar Ratio Rank of OCGN is 8585
Calmar Ratio Rank
The Martin Ratio Rank of OCGN is 7979
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Ocugen, Inc. (OCGN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for OCGN, currently valued at 1.60, compared to the broader market-4.00-2.000.002.004.001.602.51
The chart of Sortino ratio for OCGN, currently valued at 2.54, compared to the broader market-4.00-2.000.002.004.002.543.37
The chart of Omega ratio for OCGN, currently valued at 1.28, compared to the broader market0.501.001.502.001.281.47
The chart of Calmar ratio for OCGN, currently valued at 1.61, compared to the broader market0.002.004.006.001.613.63
The chart of Martin ratio for OCGN, currently valued at 5.64, compared to the broader market0.0010.0020.0030.005.6416.15
OCGN
^GSPC

The current Ocugen, Inc. Sharpe ratio is 1.60. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Ocugen, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.

Rolling 12-month Sharpe Ratio1.001.502.002.503.003.50JuneJulyAugustSeptemberOctoberNovember
1.60
2.51
OCGN (Ocugen, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Ocugen, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-99.87%
-1.75%
OCGN (Ocugen, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Ocugen, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Ocugen, Inc. was 99.97%, occurring on Jul 14, 2020. The portfolio has not yet recovered.

The current Ocugen, Inc. drawdown is 99.87%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.97%Jan 6, 20151390Jul 14, 2020
-10.6%Dec 4, 201415Dec 24, 20146Jan 5, 201521

Volatility

Volatility Chart

The current Ocugen, Inc. volatility is 23.96%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%JuneJulyAugustSeptemberOctoberNovember
23.96%
4.07%
OCGN (Ocugen, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Ocugen, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Ocugen, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items